Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis

Müller-Redetzky Holger, Kellermann Ute, Thomas Tschernig, Sandra Wienhold, Marfa Polikarpova, Katharina Hellwig, Axel Vater, Christian Maasch, Sven Klussmann, Michael Menger, Norbert Suttorp, Martin Witzenrath
European Respiratory Journal 2014 44: 1385; DOI:
Müller-Redetzky Holger
1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kellermann Ute
1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Tschernig
2Institute of Anatomy and Cell Biology, Saarland University, Faculty of Medicine, Homburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Wienhold
1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marfa Polikarpova
1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katharina Hellwig
1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Axel Vater
3NOXXON Pharma, NOXXON Pharma, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Maasch
3NOXXON Pharma, NOXXON Pharma, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven Klussmann
3NOXXON Pharma, NOXXON Pharma, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Menger
4Institute for Clinical and Experimental Surgery, Saarland University, Faculty of Medicine, Homburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norbert Suttorp
1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Witzenrath
1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Pneumonia and resultant sepsis cause high lethality despite antibiotic treatment. Uncontrolled inflammatory host responses likely contribute to unfavourable outcome by driving lung and extrapulmonary organ injury. The complement system contributes to hyperinflammation and vascular barrier failure mainly mediated by the complement fragment C5a. We investigated regulation of C5a in pneumonia and hypothesized that in pneumonia neutralizing C5a by NOX-D19 (Spiegelmer), would protect against pulmonary and extrapulmonary organ failure.

Mice infected with S. pneumonia were treated with NOX-D19. Pulmonary permeability, pulmonary and blood leukocytes, IL-1b, GSF, KC and IL-6, bacterial load in lung, spleen and blood liver and kidney function and histological analyses of fibrin deposition and apoptosis in the liver were analysed.

C5a increased in pneumonia. Lung leukocytes and cytokine increased, and moderate pulmonary permeability and bacteraemia had developed 24 h post infection. Lung failure and septic extra pulmonary organ injury developed within 48 h, displayed by a further increase of pulmonary permeability and blood cytokine levels, as well as increased AST and BUN. Hepatic fibrin deposition reflected microcirculatory failure was accompanied by apoptosis of hepatocytes. NOX-D19attenuated pulmonary permeability, reduced blood cytokine levels, protected against liver injury as judged by reduced AST levels, and abrogated hepatic fibrin deposition as well as apoptosis of hepatocytes 48 h post infection.

Conclusion: Neutralizing C5a by NOX-D19 protected against lung and extrapulmonary organ failure in pneumonia-induced sepsis.

  • Acute respiratory failure
  • Sepsis
  • Pneumonia
  • © 2014 ERS
Previous
Back to top
Vol 44 Issue Suppl 58 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis
Müller-Redetzky Holger, Kellermann Ute, Thomas Tschernig, Sandra Wienhold, Marfa Polikarpova, Katharina Hellwig, Axel Vater, Christian Maasch, Sven Klussmann, Michael Menger, Norbert Suttorp, Martin Witzenrath
European Respiratory Journal Sep 2014, 44 (Suppl 58) 1385;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis
Müller-Redetzky Holger, Kellermann Ute, Thomas Tschernig, Sandra Wienhold, Marfa Polikarpova, Katharina Hellwig, Axel Vater, Christian Maasch, Sven Klussmann, Michael Menger, Norbert Suttorp, Martin Witzenrath
European Respiratory Journal Sep 2014, 44 (Suppl 58) 1385;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Acquired coagulation disorders during extracorporeal carbon dioxide removal
  • Aggressive treatment of simple pleural effusion in ventilated patients: Pigtail catheters versus thoracostomy
  • Effect of non-patient-level factors on mortality in intensive care units
Show more 2.1 Acute Critical Care

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society